Influence of hypertension on cardiac contractile response of human erythrocyte-derived depressing factor in ventricular myocytes

Journal of Hypertension

Volumn 21, Issue 6, 2003, Pages 1183-1190

  Ren, Jun ^a,b   Wen, Yunyi ^b   Hintz, Kadon K ^c  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Erythrocyte derived depressing factor; Hypertension; Intracellular Ca2+ transients; Myocyte shortening

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; ERYTHROCYTE DERIVED DEPRESSING FACTOR; FURA 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CALCIUM CELL LEVEL; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DEVICE; DRUG EFFECT; ELECTROSTIMULATION; ESSENTIAL HYPERTENSION; FLUORESCENCE; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART VENTRICLE; MALE; MEASUREMENT; MUSCLE CONTRACTION; MUSCLE FIBER CONTRACTION; MUSCLE LENGTH; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TIME; VELOCITY;

EID: 0037864308     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200306000-00019     Document Type: Article

References (19)

1. Wen YY. The depressor effect of antihypertensive factor from rat erythrocytes. Acta Acad Med Sin 1991; 13:199-202.
2. Zhang XC, Wen YY. Action mechanisms of a new erythrocyte-derived depressing factor. Chin Sci Bull 2000; 45:743-750.
3. 2+ influx of arterial smooth muscle in rats. Chin Med J 1991; 104:376-380.
4. Xu XR, Zhang XC, Wen YY. Effect of antihypertensive factor from human erythrocyte on calcium level in human umbilical vein VSMC. Basic Med Sci Clin 1999; 19:58-62.
5. Zhang XC, Xu XR, Wen YY. Study on acute toxicity of the erythrocyte antihypertensive factor from human being. CAPS News Commun 1998; 17:167.
6. Wang XQ, Wen YY, Zhang SF. Distribution and vasodilatory effects of erythrocyte antihypertensive factor. Chin J Hypertens 1995; 3:11-13.
7. Wang Y, Wen YY. The effect of AHF and ligustrazine on cGMP levels of vascular smooth muscle from rats. Chin J Hypertens 1997; 3:185-188.
8. Ren J. Attenuated cardiac contractile responsiveness to insulin-like growth factor 1 in ventricular myocytes from biobreeding spontaneous diabetic rats. Cardiovasc Res 2000; 46:162-171.
9. Kelly RA, Balligand JL, Smith TW, Nitric oxide and cardiac function. Circ Res 1996; 79:363-380.
10. Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pr 2001; 197:65-76.
11. Fernandez-Rodriguez CM, Prieto J, Quiroga J, Zozoya JM, Andrade A, Nunez M, et al. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 1995; 21:35-40.
12. Wu GY, Wen YY, Chen MQ, Zhou XM, Zhang HY, Ji BH. Further studies on the depressor effect of erythrocytic antihypertensive factor. Acta Physiol Sin 1993; 45:262-269.
13. Wu GY, Wen YY, Chen MQ, Zhang SF, Zhou LP. Effects of antihypertensive factor from erythrocytes of essential hypertensive subjects on blood pressure in rats. Acta Physiol Sin 1991; 43:352-359.
14. Schillaci G, Vaudo G, Pasqualini L, Reboldi G, Porcellati C, Verdecchia P. Left ventricular mass and systolic dysfunction in essential hypertension. J Hum Hypertens 2002; 16:117-122.
15. Ren J, Jefferson L, Sowers JR, Brown RA. Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats. Hypertension 1999; 34:1215-1222.
16. Mohan P, Sys SU, Brutsaert DL. Positive inotropic effect of nitric oxide in myocardium. Int J Cardiol 1995; 50:233-237.
17. Ren J, Esberg LB, Combs CK, Ren BH, Chen AF. Adenovirus gene transfer of recombinant endothelial nitric oxide synthase alters contractile function in isolated ventricular myocyte via a phosphatidylinositol 3-kinase-dependent pathway (abstract). Circulation 2001; 104:11-436.
18. Vaziri ND, Ding Y, Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999; 34:558-562.
19. Nava E, Leone AM, Wiklund NP, Moncada S. Detection of release of nitric oxide by vasoactive substances in the anesthesized rat. In: Feelisch M, Busse R, Moncada S (editors): The biology of nitric oxide. London: Portland Press; 1994, pp. 179-181.